Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFUROXIME vs CEMIPLIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFUROXIME vs CEMIPLIMAB: Safety Overview

Metric CEFUROXIME CEMIPLIMAB
Total FAERS Reports 5,209 1,020
Deaths Reported 439 175
Death Rate 8.4% 17.2%
Hospitalizations 2,274 651
Average Patient Age 56.6 yrs 68.9 yrs
% Female Patients 45.1% 36.6%
FDA Approval Date Apr 16, 1998 N/A
Manufacturer Sagent Pharmaceuticals Regeneron Pharmaceuticals, Inc.
Route INTRAMUSCULAR INTRAVENOUS
Marketing Status Discontinued N/A